Related Experiment Video
Updated: Aug 13, 2026
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Glucose-insulin-potassium infusion in acute myocardial infarction: a hemodynamic study
Arend Bergstra1, Tone Svilaas, Ad F M van den Heuvel
1Department of Cardiology, Thorax Center, University Medical Center Groningen, Groningen, The Netherlands.
Insights
Glucose-insulin-potassium (GIK) infusion adjunctive to percutaneous coronary intervention (PCI) for acute myocardial infarction did not negatively impact hemodynamics. Hemodynamic measurements showed stable cardiac index and no significant adverse effects in patients without heart failure.
Area of Science:
- Cardiology
- Critical Care Medicine
- Pharmacology
Background:
- Acute myocardial infarction (AMI) management often involves primary percutaneous coronary intervention (PCI).
- Adjunctive therapies are explored to improve outcomes in AMI patients undergoing PCI.
- The hemodynamic effects of glucose-insulin-potassium (GIK) infusion in AMI patients post-PCI require investigation.
Purpose of the Study:
- To investigate the impact of glucose-insulin-potassium (GIK) infusion as an adjunctive therapy to primary percutaneous coronary intervention (PCI) on hemodynamic parameters in patients with acute myocardial infarction (AMI).
Main Methods:
- Hemodynamic measurements were conducted in 81 patients in the GIPS 2 trial.
- Measurements commenced immediately after primary PCI and continued for 12 hours.
- Data included cardiac index, diastolic pulmonary artery pressure, and pulmonary capillary wedge pressure (PCWP).
Main Results:
- Cardiac index remained stable in both GIK and non-GIK groups.
- Initial measurements revealed significantly higher diastolic pulmonary artery pressure and PCWP in the non-GIK group.
- While PCWP decreased in the non-GIK group over 6 hours, the difference in change pattern between groups did not reach statistical significance.
Conclusions:
- Glucose-insulin-potassium (GIK) infusion as adjunctive therapy to primary PCI in acute myocardial infarction patients without overt heart failure did not adversely affect hemodynamics.
- The study suggests GIK infusion is hemodynamically safe in this patient population.
- Further research may explore potential benefits beyond hemodynamic stability.
Background:
In this study, we investigated whether adjunction of glucose-insulin-potassium (GIK) infusion to primary percutaneous coronary intervention (PCI) affects hemodynamics in patients with an acute myocardial infarction.
Methods:
Hemodynamic measurements were performed in a subset of patients (n = 81) in the GIPS 2, starting immediately after PCI and continued for 12 hours.
Results:
Cardiac index values were stable in both groups. During the first measurements, diastolic pulmonary artery pressure and the pulmonary capillary wedge pressure (PCWP) were significantly higher in the non-GIK group (diastolic pulmonary artery pressure 15 +/- 5 vs 18 +/- 7 mm Hg, P = .028 and PCWP 14 +/- 6 vs 18 +/- 7 mm Hg, P = .030). There was a decrease in PCWP from 18 +/- 7 to 15 +/- 6 mm Hg in the non-GIK group during the first 6 hours, whereas the pressures remained at 14 +/- 6 mm Hg in the GIK group. This difference in pattern of change did not reach statistical significance in the analysis of the interaction of PCWP by GIK group (P = .065).
Conclusions:
Glucose-insulin-potassium infusion as adjunctive therapy to PCI in patients with acute myocardial infarction, without overt signs of heart failure, did not negatively affect hemodynamics.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
01:30Acute Coronary Syndrome III: Diagnostic Studies